切换至 "中华医学电子期刊资源库"

中华消化病与影像杂志(电子版) ›› 2024, Vol. 14 ›› Issue (06) : 555 -559. doi: 10.3877/cma.j.issn.2095-2015.2024.06.014

论著

预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值
董佳1, 王坤1, 张莉1,()   
  1. 1.266000 山东省,青岛市市立医院消化内一科
  • 收稿日期:2024-07-02 出版日期:2024-12-01
  • 通信作者: 张莉
  • 基金资助:
    山东省自然科学基金(包干制)项目(ZR2023QH301)

Prognostic nutritional index combined with immunoglobulin,fasting blood glucose level and serum alpha-fetoprotein in predicting poor prognosis in patients with HBV associated chronic acute liver failure after treatment

Jia Dong1, Kun Wang1, Li Zhang1,()   

  1. 1.First Department of Gastroenterology,Qingdao Municipal Hospital,Qingdao 266000,China
  • Received:2024-07-02 Published:2024-12-01
  • Corresponding author: Li Zhang
引用本文:

董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.

Jia Dong, Kun Wang, Li Zhang. Prognostic nutritional index combined with immunoglobulin,fasting blood glucose level and serum alpha-fetoprotein in predicting poor prognosis in patients with HBV associated chronic acute liver failure after treatment[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(06): 555-559.

目的

分析预后营养指数(PNI)结合免疫球蛋白、空腹血糖(FPG)及血清甲胎蛋白(AFP)对HBV 相关慢加急性肝衰竭(HBV-ACLF)患者治疗后预后不良的预测价值。

方法

纳入青岛市市立医院2020 年10 月至2023 年10 月收治的220 例HBV-ACLF 患者,按照治疗后预后情况,将患者分别纳入预后良好组(n=118)、预后不良组(n=102),并根据预后不良患者中是否死亡分为生存组(n=68)和死亡组(n=34)。比较不同组别患者入院时的PNI、免疫球蛋白(IgG、IgM、IgA)、FPG、AFP 指标,采用Logistic 多因素回归分析和受试者工作特征曲线计算上述指标预测HBV-ACLF 患者治疗后预后不良的价值。

结果

220 例患者中,发生预后不良102 例(46.36%),其中死亡34 例(15.45%)。预后良好组患者年龄、免疫球蛋白IgG、IgA、IgM、AFP、PNI 血糖高于预后不良组,FPG 低于预后不良组。对预后不良组内死亡组和生存组比较,死亡组年龄、免疫球蛋白IgG、IgA、IgM、AFP、PNI 血糖高于生存组,FPG 低于生存组(P<0.05)。Logistic 多因素回归分析显示,肝性脑病Ⅲ、Ⅳ期、免疫球蛋白IgG≥17 g/L、IgA≥3.8 g/L、IgM≥2.5 g/L、FPG<6.2 mmol/L、AFP≥80 mmol/L、PNI≥35均为影响HBV-ACLF患者近中期预后不良的危险因素(P<0.05)。联合肝性脑病Ⅲ、Ⅳ期、IgG、IgA、IgM、PNI、FPG、AFP 预测患者预后不良的AUC 为0.856,灵敏度、特异性为85.89%、87.69%(P<0.05)。

结论

HBV-ACLF 患者预后与患者PNI、IgG、IgM、IgA、FPG、AFP 均存在密切关联,联合监测各因素有助于为预后预测提供更可靠参考。

Objective To analyze the prognostic nutritional index (PNI) combined with immunoglobulin,fasting blood glucose (FPG) and serum alpha-fetoprotein (AFP) in predicting poor prognosis of patients with HBV associated chronic acute liver failure (HBV-ACLF) after treatment.

Methods

A total of 220 patients with HBV-ACLF admitted to Qingdao Municipal Hospital from October 2020 to October 2023 were included. According to the prognosis after treatment,the patients were respectively included in the good prognosis group (n=118) and the poor prognosis group (n=102),and patients with poor prognosis were divided into survival group (n=68) and death group (n=34) according to whether they died or not. The indexes of PNI,immunoglobulin (IgG,IgM,IgA),FPG and AFP were compared among patients in different groups at admission. Logistic multivariate regression analysis and receiver operating characteristic curve (ROC) were used to calculate the value of these indexes in predicting the poor prognosis of patients with HBV-ACLF after treatment.

Results

Among 220 patients,102 patients had poor prognosis (46.36%),and 34 patients died (15.45%). Age,immunoglobulin IgG,IgA,IgM,AFP PNI and blood glucose of patients in the good prognosis group were higher than those in the poor prognosis group,and FPG was lower than that in the poor prognosis group. Comparison between the death group and the survival group in the poor prognosis group was made,age,immunoglobulin IgG,IgA,IgM,AFP,PNI and blood glucose in the death group were higher than those in the survival group,and FPG was lower than that in the survival group (P<0.05). Logistic multivariate regression analysis showed that Stage Ⅲ and Ⅳ of hepatic encephalopathy,immunoglobulin IgG≥17 g/L,IgA≥3.8 g/L,IgM≥2.5 g/L,FPG<6.2 mmol/L,AFP≥80 mmol/L and PNI≥35 were all risk factors for poor prognosis in patients with HBV-ACLF (P<0.05). Combined with hepatic encephalopathy Ⅲ and Ⅳ,IgG,IgA,IgM,PNI,FPG and AFP,the AUC of patients with poor prognosis was 0.856,and the sensitivity and specificity were 85.89%and 87.69% (P<0.05).

Conclusion

The prognosis of patients with HBV-ACLF is closely correlated with PNI,IgG,IgM,IgA,FPG and AFP,and the combined monitoring of these factors is helpful to provide a more reliable reference for prognosis prediction.

图1 HBV 相关慢加急性肝衰竭患者预后预测的因素的研究方案
表1 两组基线资料比较
图2 各项危险因素预测HBV 相关慢加急性肝衰竭患者预后不良的ROC 曲线
表2 多因素回归分析赋值表
表3 影响HBV 相关慢加急性肝衰竭患者近中期疗效的多因素回归分析结果
表4 各项危险因素预测HBV 相关慢加急性肝衰竭患者预后不良的效能分析
[1]
Kezer CA,Simonetto DA,Shah VH. Acute on Chronic Liver Failure in Patients with Alcohol-Associated Hepatitis: A Review[J]. Clin Liver Dis,2023,27(3): 659-670.
[2]
Wu W,Sun S,Wang Y,et al. Circulating Neutrophil Dysfunction in HBV-Related Acute-on-Chronic Liver Failure[J]. Front Immunol,2021,12: 620365.
[3]
王亚敏,刘瑜珊,李娟,等. 预后营养指数对预测慢加急性肝衰竭合并感染的应用价值[J]. 中华肝脏病杂志,2024,32(3): 235-241.
[4]
Zhang L,Zhao Y,Xie Z,et al. 1,5-Anhydroglucitol Predicts Mortality in Patients with HBV-Related Acute-on-chronic Liver Failure[J]. J Clin Transl Hepatol,2022,10(4): 651-659.
[5]
张国栋,秦金环,徐伟锋. 甲胎蛋白和空腹血糖测定在HBV相关慢加急性肝功能衰竭预后判断中的意义[J]. 中国实用医刊,2012,39(5): 115-116.
[6]
中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J].临床肝胆病杂志,2019,35(1): 38-44.
[7]
Zhao W,Lei M,Li J,et al. Yes-associated protein inhibition ameliorates liver fibrosis and acute and chronic liver failure by decreasing ferroptosis and necroptosis[J]. Heliyon,2023,9(4):e15075.
[8]
Wang T,Tan W,Wang X,et al. Role of precipitants in transition of acute decompensation to acute-on-chronic liver failure in patients with HBV-related cirrhosis[J]. JHEP Rep,2022(10): 100529.
[9]
Song Z,Xie Q,Zhou Y,et al. Effect of Artificial Liver Support Systems on Gut Microbiota in Patients with HBV-Related Acute-on-Chronic Liver Failure[J]. Pathogens,2023,12(9): 1094.
[10]
陈铿,李平红,李艳玲,等. 乙型肝炎病毒相关慢加急性肝衰竭合并肝性脑病患者临床特点及预后影响因素分析[J]. 肝脏,2023,28(5): 568-571,580.
[11]
毛静,刘鑫华,杨军杰,等. 炎症和免疫指标对乙型肝炎病毒感染相关慢加急性肝衰竭预后判断价值研究进展[J/OL]. 中国肝脏病杂志(电子版),2024,16(1): 18-21.
[12]
张旭,马丽娜,王梦甜,等. 中性粒/淋巴细胞比值联合预后营养指数对乙型肝炎病毒相关慢加急性肝衰竭短期预后的预测价值[J]. 中华肝脏病杂志,2023,31(8): 847-854.
[13]
薛红,刘先进,明芳,等. 预后营养指数与乙型肝炎病毒相关慢加急性肝衰竭患者预后的关系[J]. 实用医学杂志,2022,38(10):1240-1245.
[14]
Tu H,Liu R,Zhang A,et al. Risk factors for the mortality of hepatitis B virus-associated acute-on-chronic liver failure: a systematic review and meta-analysis[J]. BMC Gastroenterol,2023,23(1): 342.
[15]
王海斌,李晖,陈晓蕾,等. 空腹血糖水平对乙型肝炎病毒相关慢加急性肝衰竭患者疾病转归的影响[J]. 实用医学杂志,2023,39(18): 2373-2378.
[16]
杨涛,苏忠,杨奕,等. HBV相关慢加急性肝衰竭血清AFP、GP73的表达与疾病预后关系分析[J]. 中西医结合肝病杂志,2021,31(12): 1078-1081.
[17]
Zhang Y,Chen P,Zhu X. Lymphocyte-to-white blood cell ratio is associated with outcome in patients with hepatitis B virus-related acute-on-chronic liver failure[J]. World J Gastroenterol,2023,29(23): 3678-3687.
[18]
耿华,徐曼曼,周丽华,等. 血清AFP、FT3联合NLR对人工肝治疗乙型肝炎病毒相关慢加急性肝衰竭患者短期预后的评估价值研究[J]. 现代生物医学进展,2022,22(11): 2076-2080.
[1] 徐婷婷, 詹泳池, 王晓东, 刘兴会. 电子胎心监测结果出现正弦波形的胎母输血综合征围生期结局分析[J]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 382-389.
[2] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[3] 吴方园, 孙霞, 林昌锋, 张震生. HBV相关肝硬化合并急性上消化道出血的危险因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 45-47.
[4] 周慧宇, 吕定阳, 双卫兵. 联合系统性免疫炎症指数和预后营养指数预测腹腔镜肾切除术后肾癌患者的预后[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(03): 225-231.
[5] 刘春军, 严方方, 王宝锋, 常婷婷, 郭红红, 李志强. 替加环素联合人免疫球蛋白治疗XDRAB致VAP 的疗效分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(05): 797-800.
[6] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[7] 胡志恒, 任洪波, 宋志远, 张运刚, 韩晓正. 血清sTIM-3及其配体Gal-9、CEACAM-1与创伤性颅脑损伤患者脑损伤程度及预后的关系[J]. 中华脑科疾病与康复杂志(电子版), 2024, 14(04): 201-207.
[8] 沈炎, 张俊峰, 唐春芳. 预后营养指数结合血清降钙素原、胱抑素C及视黄醇结合蛋白对急性胰腺炎并发急性肾损伤的预测价值[J]. 中华消化病与影像杂志(电子版), 2024, 14(06): 536-540.
[9] 崔健, 夏青, 林云, 李光玲, 李心娜, 王位. 血小板与淋巴细胞比值、免疫球蛋白、心肌酶谱及心电图对中老年肝硬化患者病情及预后的影响[J]. 中华消化病与影像杂志(电子版), 2024, 14(05): 400-406.
[10] 周庆, 杨旭. 甲胎蛋白、纤维蛋白原与前白蛋白比值、癌胚抗原、D-二聚体对结肠癌术后复发的预测价值[J]. 中华消化病与影像杂志(电子版), 2024, 14(04): 301-305.
[11] 胡静, 杨秀锦, 侯志云. HBV感染患者外周血ISGs表达水平变化及其与干扰素治疗疗效的关系[J]. 中华消化病与影像杂志(电子版), 2024, 14(04): 343-347.
[12] 莫鹏, 郭杏春, 梁秀娟, 王耀明. 超声引导与CT引导射频消融治疗肝细胞癌患者疗效及预后比较[J]. 中华消化病与影像杂志(电子版), 2024, 14(02): 151-154.
[13] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[14] 刘春林, 刘畅, 赵东岩, 李端萍, 刘建梅, 罗秋林. 利用室内质控与能力验证数据评定HBV DNA和HCV RNA测量不确定度[J]. 中华临床实验室管理电子杂志, 2024, 12(02): 91-96.
[15] 孙冠超, 万军, 石卉. IgG相关食物不耐受与肠道免疫微环境相关性的研究进展[J]. 中华胃肠内镜电子杂志, 2024, 11(03): 200-203.
阅读次数
全文


摘要